These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 521807)

  • 1. Use of the 51chromium release test to demonstrate antigenic differences between extracellular and intracellular forms of vaccinia virus.
    Balachandran N; Seth P; Mohapatra LN
    J Gen Virol; 1979 Oct; 45(1):65-72. PubMed ID: 521807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response in rabbits to surface components of extracellular and intracellular forms of vaccinia virus.
    Balachandran N; Seth P; Mohapatra LN
    Infect Immun; 1980 Sep; 29(3):846-52. PubMed ID: 7000705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors concerning the immunity to poxvirus infection.
    Tagaya I; Arita M; Amano H; Ueda Y
    Ann Microbiol (Paris); 1977 Oct; 128(3):409-16. PubMed ID: 203217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccinia virus-expressed bovine ephemeral fever virus G but not G(NS) glycoprotein induces neutralizing antibodies and protects against experimental infection.
    Hertig C; Pye AD; Hyatt AD; Davis SS; McWilliam SM; Heine HG; Walker PJ; Boyle DB
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():631-40. PubMed ID: 8627251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antigenicity and immunogenicity of the intracellular and extracellular forms of vaccinia virus. I: The production of high-titre vaccinia extracellular virus and its antigenicity after inactivation.
    Thornton B
    Br J Exp Pathol; 1980 Aug; 61(4):444-50. PubMed ID: 7426394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement.
    Lustig S; Fogg C; Whitbeck JC; Moss B
    Virology; 2004 Oct; 328(1):30-5. PubMed ID: 15380355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of measles virus-specific cytotoxic antibodies by use of a chronically infected cell line.
    Ehrnst AC
    J Immunol; 1975 Mar; 114(3):1077-82. PubMed ID: 1089724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.
    Koszinowski U; Thomssen R
    Eur J Immunol; 1975 Apr; 5(4):245-51. PubMed ID: 1086229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.
    Wong CY; Woodruff JJ; Woodruff JF
    J Immunol; 1977 Apr; 118(4):1159-64. PubMed ID: 300399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies on LS antigens induced by vaccinia and cowpox viruses.
    Ikuta K; Miyamoto H; Kato S
    J Gen Virol; 1979 Dec; 45(3):755-9. PubMed ID: 94351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin.
    Jones-Trower A; Garcia A; Meseda CA; He Y; Weiss C; Kumar A; Weir JP; Merchlinsky M
    Virology; 2005 Dec; 343(1):128-40. PubMed ID: 16165184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The existence of an envelope on extracellular cowpox virus and its antigenic relationship to the vaccinia envelope.
    Payne LG
    Arch Virol; 1986; 90(1-2):125-33. PubMed ID: 3729722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody neutralization of the extracellular enveloped form of vaccinia virus.
    Law M; Smith GL
    Virology; 2001 Feb; 280(1):132-42. PubMed ID: 11162827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single radial immunodiffusion test for detecting antibodies against surface antigens of intracellular and extracellular vaccinia virus.
    Prakash VJ; Norrby E; Payne L
    J Gen Virol; 1977 Jun; 35(3):465-72. PubMed ID: 407326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular enveloped vaccinia virus escapes neutralization.
    Ichihashi Y
    Virology; 1996 Mar; 217(2):478-85. PubMed ID: 8610439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent, complement-mediated homologous and cross-cytolysis of togavirus-infected cells.
    King B; Wust CJ; Brown A
    J Immunol; 1977 Oct; 119(4):1289-92. PubMed ID: 894036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinia virus proteins on the plasma membranes of infected cells. IV. Studies employing L cells infected with ultraviolet-irradiated vaccinia virions.
    Domber E; Holowczak JA
    Virology; 1986 Jul; 152(2):331-42. PubMed ID: 3487879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation.
    Vanderplasschen A; Hollinshead M; Smith GL
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():2041-8. PubMed ID: 9267005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of trypsin on the formation of virus-specific surface antigen in cowpox virus-infected cells.
    Tanaka J; Hatano M
    J Gen Virol; 1973 Nov; 21(2):413-6. PubMed ID: 4202786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.